Lauren Rabinovic serves as a Principal at GLS and is responsible for due diligence and monitoring of patent investments related to pharmaceutical and medical device products.
Prior to joining GLS, Lauren held leadership positions in the intellectual property groups at Abbott Laboratories and Teva Pharmaceuticals. At Abbott, Lauren developed strategies to protect and defend intellectual property for a variety of medical devices for cardiovascular care, diabetes management, chronic pain and movement disorders. Prior to Abbott, Lauren spent almost ten years at Teva, where she ultimately was responsible for the intellectual property issues for the company’s US and Canadian generic products. Before her corporate career, she was an associate at Foley Hoag and Woodcock Washburn, where she focused on life sciences-related patent litigation.
Lauren is a registered patent attorney and uses her patent litigation experience and scientific background to evaluate pharmaceutical opportunities, particularly related to Hatch-Waxman litigation. Lauren’s experience includes working with all manner of life sciences-related patents, such as small and large molecule compositions, chemical polymorphisms, drug formulations, methods of manufacture and use, and diagnostic assays, as well as advising on product lifecycle management and commercialization. She has significant experience in all phases of patent litigation, including practicing in many of the nation’s most popular patent venues, and guiding complete appellate victories before the Federal Circuit.
Lauren holds a B.S. in Biology from the University of Michigan, a Ph.D. in Neuroscience from the University of Pittsburgh and a J.D. from Boston University.